3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Peritoneal Neoplasms
2
Gastric Adenocarcinoma
2
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Neoplasms
1
Neoplasm Metastasis
1
Locally Advanced Gastric Cancer
1
Krukenberg Tumor
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Bevacizumab
35
Paclitaxel
31
Carboplatin
24
pembrolizumab
23
Specimen Handling
21
Magnetic Resonance Spectroscopy
19
Gemcitabine
18
olaparib
16
liposomal doxorubicin
16
Cyclophosphamide
15
fludarabine
12
Topotecan
12
Biopsy
12
niraparib
11
Cisplatin
10
Taxes
8
Nivolumab
8
Immunoglobulin G
8
Fulvestrant
8
Disulfides
8
Doxorubicin
7
aldesleukin
6
Surveys and Questionnaires
6
palbociclib
5
Oxaliplatin
5
Fluorouracil
5
trastuzumab deruxtecan
4
oregovomab
4
mirvetuximab soravtansine
4
X-Rays
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
90 days
×
Clear all
NCT03842982
2026-03-16
CHIPPI
Centre Oscar Lambret
Phase 3
Active not recruiting
362 enrolled